Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Calpol Six Plus 250mg/5ml oral suspension sugar free
0407010H0BEAMBG
|
Calpol | Paracetamol | Central Nervous System | 584 |
|
Calpol Infant 120mg/5ml oral suspension sugar free
0407010H0BEAEAW
|
Calpol | Paracetamol | Central Nervous System | 280 |
|
Calpol Six Plus Fastmelts 250mg tablets
0407010H0BEAQDC
|
Calpol | Paracetamol | Central Nervous System | 146 |
|
Calpol Infant Sugar Free Colour Free 120mg/5ml susp
0407010H0BEATAW
|
Calpol | Paracetamol | Central Nervous System | 68 |
|
Calpol Infant 120mg/5ml susp 5ml sachets sugar free
0407010H0BEADAJ
|
Calpol | Paracetamol | Central Nervous System | 5 |
|
Calpol Infant Original 120mg/5ml oral suspension
0407010H0BEAAAI
|
Calpol | Paracetamol | Central Nervous System | 4 |
|
Calpol Six Plus 250mg/5ml susp 5ml sachets sugar free
0407010H0BEARDE
|
Calpol | Paracetamol | Central Nervous System | 4 |
|
Calpol Infant 120mg/5ml oral suspension 5ml sachets
0407010H0BEASDJ
|
Calpol | Paracetamol | Central Nervous System | No data available |
|
Calpol Paediatric 120mg/5ml oral suspension sugar free
0407010H0BEAIAW
|
Calpol | Paracetamol | Central Nervous System | No data available |
|
Calpol Six Plus 250mg/5ml oral suspension
0407010H0BEALAC
|
Calpol | Paracetamol | Central Nervous System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.